Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 224,979,795 papers from all fields of science
Search
Sign In
Create Free Account
NC 6300
Known as:
NC-6300
, NC6300
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (2)
Epirubicin
Proteins
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Chapter 7:Anticancer Agent-Incorporating Polymeric Micelles: from Bench to Bedside
Y. Matsumura
2016
Corpus ID: 77885123
There are two main concepts in drug delivery systems (DDS): passive targeting and active targeting. The passive targeting system…
Expand
2014
2014
Abstract 2648: Enhanced antitumor effect of anti tissue factor (TF) antibody-conjugated epirubicin-incorporating polymeric micelles in human cancer xenografts with high TF expression
Yoshiyuki Yamamoto
,
I. Hyodo
,
+10 authors
Y. Matsumura
2014
Corpus ID: 56585207
Background: Anticancer agent-incorporating polymeric micelles, categorized as passive targeting agents, are expected to…
Expand
2013
2013
Abstract 4525: Combined antitumor activity of the epirubicin-incorporating polymeric micelle NC-6300 and the DACHPt-incorporating polymeric micelle NC-4016 in mice bearing human gastric cancer…
Yoshiyuki Yamamoto
,
I. Hyodo
,
+6 authors
Y. Matsumura
2013
Corpus ID: 71169809
Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC Background: Several anticancer agent (ACA…
Expand
2012
2012
Abstract LB-11: Reduced cardiotoxicity and improved antitumor effect of the epirubicin-incorporating micelle NC-6300 in a hepatocellular carcinoma model
Yoshiyuki Yamamoto
,
I. Hyodo
,
+8 authors
Y. Matsumura
2012
Corpus ID: 76412436
Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL Background: Epirubicin, an anthracycline antitumor…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE